Cellmover was established in 2015 by professor in immunology and pharmacology Marit Inngjerdingen and serial entrepreneur Eirik Næss-Ulseth and currently employs two full-tie scientist with PhDs in immunology, biochemistry and cellular biology, and with experience from previous start-up biotech companies. We are located within the Oslo Cancer Cluster Incubator with close contact to major players in the cancer research field.